JP2017521499A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017521499A5 JP2017521499A5 JP2017523191A JP2017523191A JP2017521499A5 JP 2017521499 A5 JP2017521499 A5 JP 2017521499A5 JP 2017523191 A JP2017523191 A JP 2017523191A JP 2017523191 A JP2017523191 A JP 2017523191A JP 2017521499 A5 JP2017521499 A5 JP 2017521499A5
- Authority
- JP
- Japan
- Prior art keywords
- conp
- radiation
- chemotherapeutic agent
- administered
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462025861P | 2014-07-17 | 2014-07-17 | |
| US62/025,861 | 2014-07-17 | ||
| PCT/US2015/040869 WO2016011328A1 (en) | 2014-07-17 | 2015-07-17 | Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020086617A Division JP2020158507A (ja) | 2014-07-17 | 2020-05-18 | 放射線、酸化セリウムナノ粒子、及び化学療法剤の併用によるがんの治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017521499A JP2017521499A (ja) | 2017-08-03 |
| JP2017521499A5 true JP2017521499A5 (https=) | 2018-08-23 |
| JP6706255B2 JP6706255B2 (ja) | 2020-06-03 |
Family
ID=55079076
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017523191A Expired - Fee Related JP6706255B2 (ja) | 2014-07-17 | 2015-07-17 | 放射線、酸化セリウムナノ粒子、及び化学療法剤の併用によるがんの治療 |
| JP2020086617A Pending JP2020158507A (ja) | 2014-07-17 | 2020-05-18 | 放射線、酸化セリウムナノ粒子、及び化学療法剤の併用によるがんの治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020086617A Pending JP2020158507A (ja) | 2014-07-17 | 2020-05-18 | 放射線、酸化セリウムナノ粒子、及び化学療法剤の併用によるがんの治療 |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP3628308A1 (https=) |
| JP (2) | JP6706255B2 (https=) |
| CN (2) | CN111184733A (https=) |
| AU (1) | AU2015289504B2 (https=) |
| BR (1) | BR112017000800A8 (https=) |
| CA (1) | CA2955384C (https=) |
| MX (1) | MX387363B (https=) |
| RU (2) | RU2019133284A (https=) |
| WO (1) | WO2016011328A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10512761B2 (en) | 2009-12-02 | 2019-12-24 | Renovorx, Inc. | Methods for delivery of therapeutic materials to treat pancreatic cancer |
| WO2014197362A1 (en) | 2013-06-03 | 2014-12-11 | Ramtin Agah | Devices, methods and kits for delivery of therapeutic materials to a pancreas |
| BR112017000800A8 (pt) * | 2014-07-17 | 2023-04-25 | Biocurity Holdings Inc | Tratamento do câncer com uma combinação de radiação, nanoparticulas de óxido de cério, e um agente quimioterápico |
| WO2017174437A1 (en) * | 2016-04-05 | 2017-10-12 | Hospital Clínic De Barcelona | Ceria nanoparticles for use in the treatment of hepatocellular carcinoma |
| ES2928773T3 (es) | 2017-01-17 | 2022-11-22 | Heparegenix Gmbh | Inhibidores de proteína cinasas para fomentar la regeneración hepática o reducir o prevenir la muerte de hepatocitos |
| EP3609329A4 (en) * | 2017-04-12 | 2021-03-17 | Bhagwandin, Vikash J. | COMPOSITIONS, PACKAGED MEDICINAL PRODUCTS AND METHODS OF USE OF POSACONAZOLE FOR RESISTANT TUMORS Awareness |
| BR112019022280A2 (pt) * | 2017-04-28 | 2020-05-19 | Seattle Genetics Inc | tratamento de cânceres de her2 positivo |
| US11052224B2 (en) | 2017-05-18 | 2021-07-06 | Renovorx, Inc. | Methods for treating cancerous tumors |
| US10695543B2 (en) | 2017-05-18 | 2020-06-30 | Renovorx, Inc. | Methods for treating cancerous tumors |
| US12290564B2 (en) | 2017-05-18 | 2025-05-06 | Renovorx, Inc. | Methods and apparatuses for treating tumors |
| WO2019124603A1 (ko) * | 2017-12-22 | 2019-06-27 | 경상대학교병원 | Iwr-1을 유효성분으로 함유하는 켈로이드 예방 또는 치료용 조성물 |
| KR102102535B1 (ko) * | 2018-07-26 | 2020-04-21 | 서울대학교산학협력단 | 방사선 보호 나노입자 |
| WO2020069292A1 (en) * | 2018-09-28 | 2020-04-02 | The Regents Of The University Of Colorado, A Body Corporate | Methods for preventing and treating pulmonary inflammation and fibrosis |
| RU2699670C1 (ru) * | 2018-11-16 | 2019-09-09 | Объединенный Институт Ядерных Исследований (Оияи) | Способ повышения частоты образования двунитевых разрывов днк в клетках человека при действии ионизирующих излучений в условиях влияния радиомодификаторов |
| EP4125364A4 (en) * | 2020-04-30 | 2024-09-04 | University of Central Florida Research Foundation, Inc. | Dispensable nanoparticle based composition for disinfection |
| WO2023025312A1 (zh) | 2021-08-27 | 2023-03-02 | 深圳艾欣达伟医药科技有限公司 | 使用th-302治疗parp抑制剂耐药的患者 |
| CN117651548B (zh) | 2021-08-27 | 2026-03-03 | 深圳艾欣达伟医药科技有限公司 | 冻干制剂溶液及冻干制剂、方法和用途 |
| US20250186468A1 (en) | 2022-03-15 | 2025-06-12 | Ascentawits Pharmaceuticals, Ltd. | Method for treating patient with brca-mutated cancer |
| CN119384281A (zh) | 2022-04-15 | 2025-01-28 | 深圳艾欣达伟医药科技有限公司 | 使用th-302单药或联用parp抑制剂治疗癌症的方法 |
| CN119233822A (zh) | 2022-05-23 | 2024-12-31 | 深圳艾欣达伟医药科技有限公司 | 烷化剂前药与细胞周期抑制剂联用治疗癌症的方法 |
| CN119894521A (zh) | 2022-09-22 | 2025-04-25 | 深圳艾欣达伟医药科技有限公司 | 乏氧激活的化合物在制备治疗癌症患者的药物中的用途 |
| KR20250160163A (ko) | 2023-02-27 | 2025-11-11 | 아센타위츠 파마슈티컬즈 리미티드 | 용액, 동결건조 제형, 동결건조 제형 단위 패키지, 주사제, 및 주사제 제조 방법 |
| WO2025026214A1 (zh) | 2023-07-28 | 2025-02-06 | 深圳艾欣达伟医药科技有限公司 | 治疗p53基因突变或缺陷阴性癌症、肿瘤患者 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6099798A (en) | 1997-10-31 | 2000-08-08 | Nanogram Corp. | Ultraviolet light block and photocatalytic materials |
| TWI323662B (en) * | 2002-11-15 | 2010-04-21 | Telik Inc | Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy |
| US8703200B2 (en) | 2005-04-29 | 2014-04-22 | The Board Of Regents Of The University Of Oklahoma | Inhibition of neovascularization by cerium oxide nanoparticles |
| WO2007002662A2 (en) * | 2005-06-27 | 2007-01-04 | Edward Via Virginia College Of Osteopathic Medicine | Anti-inflammatory, radioprotective, and longevity enhancing capabilities of cerium oxide nanoparticles |
| PE20091180A1 (es) * | 2007-12-27 | 2009-08-26 | Infinity Pharmaceuticals Inc | Tratamientos terapeuticos contra el cancer |
| US20100015042A1 (en) * | 2008-07-03 | 2010-01-21 | Ramot At Tel Aviv University Ltd. | Combine radiation therapy and chemotherapy for treating cancer |
| GB0921596D0 (en) * | 2009-12-09 | 2010-01-27 | Isis Innovation | Particles for the treatment of cancer in combination with radiotherapy |
| US9393439B2 (en) * | 2010-03-01 | 2016-07-19 | Intraop Medical Corporation | Radiotherapy combined with hypoxic cell sensitizers |
| US20120251496A1 (en) * | 2011-03-31 | 2012-10-04 | Telik, Inc. | Ezatiostat for treating multiple myeloma |
| US9415065B2 (en) * | 2012-04-04 | 2016-08-16 | University Of Central Florida Research Foundation, Inc. | Methods of using cerium oxide nanoparticles to mitigate or protect against radiation injury |
| IN2014DN10550A (https=) * | 2012-06-13 | 2015-08-21 | Cerion Entpr Llc | |
| EP2928877B1 (en) * | 2012-12-06 | 2020-01-22 | Merck Sharp & Dohme Corp. | Disulfide masked prodrug compositions and methods |
| EP3134347B1 (en) * | 2014-04-25 | 2019-04-10 | The Regents of The University of Michigan | Nanoparticle for use in the therapy of cancer |
| BR112017000800A8 (pt) * | 2014-07-17 | 2023-04-25 | Biocurity Holdings Inc | Tratamento do câncer com uma combinação de radiação, nanoparticulas de óxido de cério, e um agente quimioterápico |
| GB201506381D0 (en) * | 2015-04-15 | 2015-05-27 | Isis Innovation | Embolization particle |
-
2015
- 2015-07-17 BR BR112017000800A patent/BR112017000800A8/pt not_active Application Discontinuation
- 2015-07-17 RU RU2019133284A patent/RU2019133284A/ru unknown
- 2015-07-17 CN CN201911066034.XA patent/CN111184733A/zh not_active Withdrawn
- 2015-07-17 WO PCT/US2015/040869 patent/WO2016011328A1/en not_active Ceased
- 2015-07-17 EP EP19207165.2A patent/EP3628308A1/en not_active Withdrawn
- 2015-07-17 EP EP15822181.2A patent/EP3169312B1/en not_active Not-in-force
- 2015-07-17 JP JP2017523191A patent/JP6706255B2/ja not_active Expired - Fee Related
- 2015-07-17 CN CN201580038961.4A patent/CN106604719B/zh active Active
- 2015-07-17 MX MX2017000578A patent/MX387363B/es unknown
- 2015-07-17 RU RU2017104909A patent/RU2704811C2/ru active
- 2015-07-17 CA CA2955384A patent/CA2955384C/en active Active
- 2015-07-17 AU AU2015289504A patent/AU2015289504B2/en not_active Ceased
-
2020
- 2020-05-18 JP JP2020086617A patent/JP2020158507A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017521499A5 (https=) | ||
| RU2019133284A (ru) | Лечение рака комбинацией лучевой терапии, наночастиц оксида церия и химиотерапевтического средства | |
| JP2022009090A5 (https=) | ||
| JP2022022264A5 (https=) | ||
| NZ604029A (en) | Methods of treating bladder cancer | |
| JP5543956B2 (ja) | 癌の処置のための方法および組成物 | |
| JP2014515373A5 (https=) | ||
| JP2013522303A5 (https=) | ||
| CA2531862A1 (en) | Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability | |
| AR070047A1 (es) | Tratamientos terapeuticos contra el cancer. composicion que comprende un inhibidor de hedgehog. | |
| JP2014516942A5 (https=) | ||
| RU2017119230A (ru) | Лечение пигментной дистрофии сетчатки n-ацетилцистеинамидом | |
| JP2018526460A5 (https=) | ||
| JP2013518124A5 (https=) | ||
| HRP20192189T1 (hr) | Doziranja i terapijske primjene l-4-klorokinurenina | |
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2019508476A5 (https=) | ||
| JP2021169534A5 (https=) | ||
| Tu et al. | Localized delivery of nanomedicine and antibodies for combating COVID-19 | |
| Parveen et al. | Phytonanomedicine: a therapeutic approach for cervical cancer | |
| JP2012525358A5 (https=) | ||
| EP2832356B1 (en) | Administration of a therapeutic amount of genistein to mitigate erectile dysfunction resulting from radiation therapy for prostate cancer | |
| JP2016505050A5 (https=) | ||
| JP2023522415A5 (https=) | ||
| JP2011500589A5 (https=) |